|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||119.36 - 120.40|
|52 Week Range||97.13 - 120.74|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.25%|
After success in the company's phase 1/2 trial with BMN 270, an investigational gene therapy for hemophilia A, BioMarin Pharmaceuticals (BMRN) is expected to start phase 3 trials.
With the Edwards Intuity Elite valve system, Edwards Lifesciences aims to offer a minimally invasive therapy to complex aortic stenosis patients.
Of the 18 analysts tracking Southwest Airlines (LUV), six (33.3%) have rated the stock a "strong buy," and another six (33.3%) have recommended a "buy."
Given Apple's stock outperformance this year, it's not surprising to see it at the top of many equity growth funds' holdings.
A total of 20 analysts were analyzing BioMarin Pharmaceuticals in July 2017. Six analysts recommended a “strong buy,” while nine analysts suggested a “buy.”
UAA is covered by 34 Wall Street analysts who together rate the company a 2.9 on a scale of 1.0 for "strong buy" to 5.0 for "sell."
After posting better 1Q17 earnings on April 25, Chipotle's stock price rose to $496.14 by May 16, 2017. Since then, it has experienced downward momentum.
In 1Q17, WellCare Health Plans’ (WCG) Medicaid business reported revenues close to $2.6 billion, which equals year-over-year growth of ~11.8%.
In 1Q17, Baskin-Robbins, which operates under the umbrella of Dunkin' Brands (DNKN), had SSSG of -2.4% in the United States and -2.0% in international markets.
UAA's top line expanded 22% YoY (year-over-year) in fiscal 2016 to $4.8 billion, as compared to its 30% average top-line growth between fiscal 2011 to fiscal 2015.
According to a Reuters consensus, of the 28 analysts tracking Marriott (MAR), five of them (18.0%) have a “strong buy” for the stock.
Marriott's cash dividend ratio was 3.0x at the end of 3Q16, which indicates its ability to sustain dividend payouts.
Same-store sales growth Same-store sales growth (or SSSG), expressed as a percentage, is a measure of the rise in revenue from a company’s existing restaurants over a certain period of…
In 4Q16, Under Armour’s adjusted earnings per diluted share stood at $0.23, which was $0.02 lower than what analysts were expecting.
Under Armour's (UAA) Class A shares are rated 2.3 on a scale of 1.0 for "strong buy" to 5.0 for "sell." Class C shares have a higher rating of 1.0.
International sales account for about 15.0% of UAA’s total sales compared to less than 6.0% in fiscal 2013. It has plans to further expand that business.